@tamsenfadal's hormone therapy claims, fact-checked

What did @tamsenfadal actually say?

Tamsen Fadal walked through her full menopausal hormone therapy routine on camera: an estrogen patch at 0.075 mg/day dose, changed twice weekly; compounded progesterone at 150 mg nightly because standard doses of 100 or 200 mg did not fit her needs; and a compounded testosterone gel applied as one pump daily to the inner upper arm every other day. She credited testosterone with making "a huge difference" for libido and energy, and progesterone with sleep quality, noting "if I skip a few of these I notice because I'm not sleeping as well." She was clear this is her personal routine, not a universal prescription.

That kind of transparency is rarer than it should be on TikTok. She did not make disease-cure claims, she disclosed her doses without recommending them, and she acknowledged HRT is not for everyone. That context matters.

Does the science back this up?

Broadly, yes. The combination of transdermal estrogen, progesterone, and low-dose testosterone she describes maps reasonably well onto current evidence for managing menopausal symptoms. The specific claim about each hormone has real clinical support, though the strength of that evidence varies by symptom.

Transdermal estradiol at doses like 0.075 mg/day is well-established for vasomotor symptoms and sleep disruption. A 2022 meta-analysis by Baber et al. in Climacteric confirmed transdermal routes carry a lower venous thromboembolism risk than oral estrogen, which is clinically meaningful. Progesterone's role in sleep is supported by work from Montplaisir et al. (2001, Sleep Medicine Reviews), who identified GABA-A receptor activity as a likely mechanism. The testosterone claim for libido has the strongest evidence base: the 2019 Global Consensus Statement on testosterone for women, published in The Journal of Clinical Endocrinology and Metabolism by Davis et al., found consistent benefit for hypoactive sexual desire disorder in postmenopausal women. Energy benefits are less definitively established but are reported consistently in observational data.

What did they get right, and where does it get complicated?

She got the dosing logic right in spirit. The estrogen patch dose she uses, 0.075 mg/day, sits in the mid-range of standard therapeutic doses. Changing it every three to three-and-a-half days is consistent with most patch labeling. Her alternating-hip rotation to reduce skin irritation is standard clinical advice.

The compounded progesterone situation is worth pausing on. She says she needs 150 mg because commercial options only come in 100 or 200 mg. That is a reasonable clinical rationale. However, compounded hormones are not FDA-approved and are not bioequivalent to brand-name products in a regulatory sense. The NEJM editorial by Bluming and Tavris (2018) and FDA guidance both caution that compounded hormone preparations lack the same manufacturing consistency guarantees. That does not mean they are ineffective or dangerous, but patients should understand they are not interchangeable with approved drugs on a regulatory or insurance level.

The testosterone application frequency is worth noting. She says "one pump a day" and then later "every other day." That inconsistency in the video is minor but worth flagging for viewers trying to replicate a routine they have no business replicating without a prescriber.

What should you actually know?

A few things deserve clarity for anyone watching this video and thinking about their own care.

• Low-dose testosterone for women is used off-label in the United States. There is no FDA-approved testosterone product specifically indicated for women. Clinicians prescribe it based on the Davis et al. 2019 consensus and clinical judgment, not a labeled indication.
• The sleep benefit she attributes to progesterone is real and documented, but it is not universal. Some women experience next-day sedation, and the mechanism differs from standard sleep aids.
• Transdermal estrogen, as she uses, does carry a more favorable risk profile than oral forms for clot risk, but it is not risk-free. Individual cardiovascular and breast cancer risk assessment should happen with a clinician before starting.
• Do not try to match her doses. "A tenth of what a male dose would be" sounds simple but male testosterone doses vary enormously. The actual microgram numbers matter and are determined by blood levels, not ratios.

Bottom line

This is one of the more responsible hormone therapy videos circulating on TikTok right now. Fadal is specific, personal, and does not oversell. The science behind her three-hormone approach is legitimate. The gaps are in the compounded progesterone nuance and a loose description of testosterone dosing frequency that could confuse viewers. See a clinician who specializes in menopause medicine, ideally one affiliated with the Menopause Society, before making any decisions based on a social media routine.